Gjithçka që të intereson, në një vend
Ndiq feed-e: blogje, lajme, RSS dhe më shumë. Një mënyrë e lehtë për të lexuar dhe përvetësuar përmbajtjen që zgjedh vetë.
Merr FeederRSS feeds për Farmaceutikë
Burimet RSS për Farmaceutikë që përdoruesit e Feeder ndjekin më shumë, duke përfshirë ClinicalTrials.gov: NCFB | Last update posted in the last 14 days, ClinicalTrials.gov: Amyloidosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days dhe Bayer Global PR | GU. Kopjoni URL-në e një burimi ose ndiqini falas në Feeder.
Tema të ngjashme
RSS feeds për Shëndeti RSS feeds për Onkologji RSS feeds për Prova klinike RSS feeds për Kërkime mjekësore RSS feeds për Shëndet mendor RSS feeds për Psikologji RSS feeds për Shëndet publik
Sugjero një ndryshimClinicalTrials.gov: NCFB | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: NCFB | Last update posted in the last 14 days
ClinicalTrials.gov: Amyloidosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Amyloidosis | Phase: 1, 2, 3 | Interventional studies | Last update posted in the last 14 days
Nxera Pharma | IR English (Narcolepsy)
Nxera Pharma Investors information IR News page.
Business Wire - News by Company: Bayer
Business Wire - The global leader in news distribution
ClinicalTrials.gov: SKB410 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: SKB410 | Last update posted in the last 14 days
ClinicalTrials.gov: CRB-701 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: CRB-701 | Last update posted in the last 14 days
ClinicalTrials.gov: LY4052031 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: LY4052031 | Last update posted in the last 14 days
ClinicalTrials.gov: MK-3120 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: MK-3120 | Last update posted in the last 14 days
ClinicalTrials.gov: AKY-1189 | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: AKY-1189 | Last update posted in the last 14 days
ClinicalTrials.gov: Other terms: RSV vaccine | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: RSV vaccine | Last update posted in the last 14 days
ClinicalTrials.gov: Homozygous Familial Hypercholesterolemia | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Homozygous Familial Hypercholesterolemia | Last update posted in the last 14 days
ClinicalTrials.gov: Other terms: Pfizer | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: Pfizer | Last update posted in the last 14 days
ClinicalTrials.gov: Other terms: Sanofi | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Other terms: Sanofi | Last update posted in the last 14 days
J&J PR | GU
Explore all Johnson & Johnson published press releases by date and/or topic of news.
Global News | Astellas | GU
Explore Astellas’ global press releases and discover the latest news and updates about Astellas.
Bayer | LinkedIn
Bayer | 6,769,296 followers on LinkedIn. Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population.
Bayer UK | LinkedIn
Bayer UK | 7,724 followers on LinkedIn. Bayer in the UK | Bayer is a global life science company with core interests in healthcare and agriculture. At Bayer, our mission of “Health for All, Hunger for None” drives our commitment to addressing societal and environmental needs, benefiting people and improving their quality of life. Through research and innovation, we aim to reimagine how we care for ourselves, and one another, by empowering everyday health, improving approaches to patient care,